[1]
S. R. Kalva, S. R. Kalva, and S. K. Gumme, “Regulatory architecture of biosimilars in Singapore: A critical overview”, Int J Drug Reg Affairs, vol. 7, no. 3, pp. 34-39, Sep. 2019.